HR4396119th CongressWALLET

Uterine Cancer Study Act of 2025

Sponsored By: Representative Clarke, Yvette D. [D-NY-9]

Introduced

Summary

Study of hair straighteners and uterine cancer risk, focused on impacts for women of color. This bill would direct the Secretary of Health and Human Services to lead a coordinated study with the Food and Drug Administration and the National Institutes of Health to review evidence, disaggregate results by race and by product treatments, and assess whether manufacturers need additional safety testing for chemical hair straighteners.

Show full summary
  • Women and families: The study would provide clearer evidence about potential links between chemical hair straighteners and uterine cancer, with attention to whether risks are higher for women of color. The results will be broken down by whether products include dyes, bleach, highlights, or perms.
  • Regulators and manufacturers: The review must evaluate whether the FDA should impose extra testing requirements on hair straightener makers to ensure product safety.
  • Researchers and lawmakers: The bill requires HHS to describe its study method to relevant congressional committees within 45 days and to deliver a final report within 2 years.

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Study on hair straighteners and uterine cancer

If enacted, HHS would study links between chemical hair straighteners and uterine cancer. HHS would work with FDA and NIH. The study would look at higher rates among women of color and impacts across all groups. Results would be broken out by products with dyes, coloring, bleach, highlights, or perms. It would review past research and say if FDA should require extra safety testing for makers. HHS would send a study plan to Congress within 45 days, start within 180 days, and report within 2 years.

Sponsors & CoSponsors

Sponsor

Clarke, Yvette D. [D-NY-9]

NY • D

Cosponsors

  • Rep. Brown, Shontel M. [D-OH-11]

    OH • D

    Sponsored 7/15/2025

  • Rep. Watson Coleman, Bonnie [D-NJ-12]

    NJ • D

    Sponsored 7/15/2025

  • Rep. Kelly, Robin L. [D-IL-2]

    IL • D

    Sponsored 7/15/2025

  • Scott, David

    GA • D

    Sponsored 7/15/2025

  • Del. Norton, Eleanor Holmes [D-DC-At Large]

    DC • D

    Sponsored 7/15/2025

  • Sewell

    AL • D

    Sponsored 7/15/2025

  • Rep. Foushee, Valerie P. [D-NC-4]

    NC • D

    Sponsored 7/15/2025

  • McClellan

    VA • D

    Sponsored 7/15/2025

  • Rep. Velázquez, Nydia M. [D-NY-7]

    NY • D

    Sponsored 7/15/2025

  • Rep. Fields, Cleo [D-LA-6]

    LA • D

    Sponsored 7/15/2025

  • Rep. Dingell, Debbie [D-MI-6]

    MI • D

    Sponsored 7/15/2025

  • Rep. Tlaib, Rashida [D-MI-12]

    MI • D

    Sponsored 7/15/2025

  • Trahan

    MA • D

    Sponsored 7/15/2025

  • Johnson (GA)

    GA • D

    Sponsored 7/15/2025

  • Rep. Ansari, Yassamin [D-AZ-3]

    AZ • D

    Sponsored 7/15/2025

  • Rep. Thanedar, Shri [D-MI-13]

    MI • D

    Sponsored 7/15/2025

  • Thompson (MS)

    MS • D

    Sponsored 7/15/2025

  • Rep. Krishnamoorthi, Raja [D-IL-8]

    IL • D

    Sponsored 7/15/2025

  • Rep. Salinas, Andrea [D-OR-6]

    OR • D

    Sponsored 7/15/2025

  • Rep. McIver, LaMonica [D-NJ-10]

    NJ • D

    Sponsored 7/15/2025

  • Rep. Carter, Troy A. [D-LA-2]

    LA • D

    Sponsored 7/15/2025

  • Wilson (FL)

    FL • D

    Sponsored 7/15/2025

  • Rep. Lee, Summer L. [D-PA-12]

    PA • D

    Sponsored 7/15/2025

  • Rep. Wasserman Schultz, Debbie [D-FL-25]

    FL • D

    Sponsored 7/15/2025

  • Rep. Figures, Shomari [D-AL-2]

    AL • D

    Sponsored 7/15/2025

  • Adams

    NC • D

    Sponsored 7/15/2025

  • Khanna

    CA • D

    Sponsored 7/15/2025

  • Rep. Meeks, Gregory W. [D-NY-5]

    NY • D

    Sponsored 7/15/2025

  • Rep. Green, Al [D-TX-9]

    TX • D

    Sponsored 7/15/2025

  • Rep. Tokuda, Jill N. [D-HI-2]

    HI • D

    Sponsored 7/15/2025

  • Rep. Rivas, Luz M. [D-CA-29]

    CA • D

    Sponsored 7/15/2025

  • Mannion

    NY • D

    Sponsored 7/15/2025

  • Fletcher

    TX • D

    Sponsored 7/21/2025

  • Rep. Underwood, Lauren [D-IL-14]

    IL • D

    Sponsored 8/12/2025

  • Rep. Brownley, Julia [D-CA-26]

    CA • D

    Sponsored 8/12/2025

  • Rep. Waters, Maxine [D-CA-43]

    CA • D

    Sponsored 8/12/2025

  • Rep. Pressley, Ayanna [D-MA-7]

    MA • D

    Sponsored 8/12/2025

  • Davis (NC)

    NC • D

    Sponsored 8/12/2025

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation